Catheter in the Prevention of Urinary Tract Infections and Crystallization Study(CPUTICS)
Launched by SHANGHAI EAST HOSPITAL · Jan 27, 2024
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Catheter in the Prevention of Urinary Tract Infections and Crystallization Study (CPUTICS) is a clinical trial that aims to compare two types of urinary catheters: Parylene-coated catheters and silicone catheters. The goal is to see which type of catheter better prevents urinary tract infections and the formation of crystals in the urine. This study is important because urinary catheters are often used in patients who need help urinating, and infections can be a serious concern.
To participate in this study, individuals must be at least 18 years old and have had a urinary catheter in place for at least 14 days. However, there are some conditions that may prevent someone from joining, such as having a urinary tract infection before starting the catheter or having certain medical issues like kidney problems or allergies to silicone. If eligible, participants will be asked to sign a consent form, which means they fully understand the study and agree to take part. Since this trial is not yet recruiting, more information will be available when it starts.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. age greater than 18 years;
- • 2. indwelling urinary catheter for ≥14 days;
- • 3. fully understand the clinical trial protocol and sign the informed consent;
- Exclusion Criteria:
- • 1. patients with confirmed urinary tract infection before indwelling urinary catheter;
- • 2. those with renal dysfunction;
- • 3. those who are allergic to silicone or silicone material;
- • 4. those with low immunity susceptible to infection;
- • 5. those who have participated in other clinical trials within 3 months;
- • 6. others who are judged by the investigator to be unsuitable for clinical trials;
About Shanghai East Hospital
Shanghai East Hospital, affiliated with Tongji University, is a leading healthcare institution in China dedicated to providing high-quality medical services, education, and research. Renowned for its advanced clinical practices and cutting-edge technologies, the hospital plays a pivotal role in the advancement of medical science through innovative research and clinical trials. Committed to improving patient outcomes, Shanghai East Hospital collaborates with various stakeholders to explore new therapies and treatment modalities, enhancing the collective understanding of health and disease. Their clinical trial initiatives focus on addressing pressing medical needs while ensuring the highest ethical standards and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
haifeng wang
Principal Investigator
Shanghai East Hospital,Tongji University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported